DK518984D0 - Zinkforbindelser og farmaceutiske praeparater indeholdende disse - Google Patents

Zinkforbindelser og farmaceutiske praeparater indeholdende disse

Info

Publication number
DK518984D0
DK518984D0 DK518984A DK518984A DK518984D0 DK 518984 D0 DK518984 D0 DK 518984D0 DK 518984 A DK518984 A DK 518984A DK 518984 A DK518984 A DK 518984A DK 518984 D0 DK518984 D0 DK 518984D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
preparations containing
zinc compounds
zinc
compounds
Prior art date
Application number
DK518984A
Other languages
English (en)
Other versions
DK162840B (da
DK162840C (da
DK518984A (da
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of DK518984D0 publication Critical patent/DK518984D0/da
Publication of DK518984A publication Critical patent/DK518984A/da
Publication of DK162840B publication Critical patent/DK162840B/da
Application granted granted Critical
Publication of DK162840C publication Critical patent/DK162840C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK518984A 1983-10-31 1984-10-31 Zink(ii)-komplekser af substituerede 3-hydroxypyroner eller 3-hydroxypyridoner, anvendelse af disse samt farmaceutiske praeparater indeholdende disse DK162840C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838329043A GB8329043D0 (en) 1983-10-31 1983-10-31 Pharmaceutical compositions
GB8329043 1983-10-31

Publications (4)

Publication Number Publication Date
DK518984D0 true DK518984D0 (da) 1984-10-31
DK518984A DK518984A (da) 1985-05-01
DK162840B DK162840B (da) 1991-12-16
DK162840C DK162840C (da) 1992-05-04

Family

ID=10551002

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518984A DK162840C (da) 1983-10-31 1984-10-31 Zink(ii)-komplekser af substituerede 3-hydroxypyroner eller 3-hydroxypyridoner, anvendelse af disse samt farmaceutiske praeparater indeholdende disse

Country Status (16)

Country Link
US (2) US4665064A (da)
EP (1) EP0145228B1 (da)
JP (1) JPH0655722B2 (da)
AU (1) AU584590B2 (da)
CA (1) CA1290096C (da)
CY (1) CY1678A (da)
DE (1) DE3484098D1 (da)
DK (1) DK162840C (da)
GB (2) GB8329043D0 (da)
HK (1) HK97492A (da)
IE (1) IE57801B1 (da)
IL (1) IL73379A (da)
NZ (1) NZ210057A (da)
PH (1) PH27408A (da)
SG (1) SG101992G (da)
ZA (1) ZA848501B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
US4822786A (en) * 1986-07-01 1989-04-18 Kaken Pharmaceutical Co., Ltd. Cephalosporin compounds, and antibacterial agents
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
US5574027A (en) * 1989-11-22 1996-11-12 Bernstein; Lawrence R. Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5258376A (en) * 1989-11-22 1993-11-02 Bernstein Lawrence R Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
WO1993009776A1 (en) * 1991-11-12 1993-05-27 Lawrence Richard Bernstein Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
JPH07111202B2 (ja) * 1992-05-18 1995-11-29 株式会社ゼネラルエンジニアリング ダブルピストン形トルクアクチュエータ
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
US5372822A (en) * 1994-03-07 1994-12-13 Fahim; Mostafa S. Chemical castration
DE69633178T2 (de) 1995-06-10 2005-08-11 Vitra Pharmaceuticals Ltd., Saffron Walden Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
AU1033400A (en) * 1998-09-23 2000-04-17 Joiner, Andrew Oral composition with an improved teeth whitening effect
US6767741B1 (en) 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
JP2001220348A (ja) * 1999-11-30 2001-08-14 Japan Science & Technology Corp 亜鉛（ｉｉ）有機錯体からなる血糖降下剤
DE19961256A1 (de) * 1999-12-18 2001-06-21 Clariant Gmbh Kosmetische Zubereitungen
AU2001287850A1 (en) * 2000-09-19 2002-04-02 Vitra Pharmaceuticals Limited Iron compositions
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
US20060094777A1 (en) * 2004-11-01 2006-05-04 Westfall Geoffrey J Teat disinfectant having zinc EDTA, and methods
CL2007002026A1 (es) * 2006-07-13 2008-06-06 Los Angeles Biomed Res Inst Composicion que comprende al menos un compuesto quelante de hierro y al menos un agente antifungico; y metodo para el tratamiento o prevencion de una condicion fungica.
TWI404533B (zh) * 2007-03-28 2013-08-11 Apotex Technologies Inc 去鐵酮（ｄｅｆｅｒｉｐｒｏｎｅ）之氟化衍生物
EA022751B1 (ru) 2008-04-25 2016-02-29 Апотекс Текнолоджиз Инк. Жидкая композиция деферипрона с замаскированным вкусом
DK2448922T3 (da) * 2009-07-03 2014-11-10 Apotex Technologies Inc Fluorinerede derivater af 3-hydroxypyridin-4-oner
CN102010790B (zh) * 2010-11-24 2012-09-19 湖南中烟工业有限责任公司 麦芽酚或乙基麦芽酚的锌配合物的应用
CN102028305B (zh) * 2010-11-24 2013-11-27 湖南中烟工业有限责任公司 一类邻羟基酮类化合物的锌配合物的应用
EP2704799A4 (en) * 2011-05-06 2014-10-29 Lankenau Inst Medical Res COMPOSITIONS AND METHOD FOR PREVENTING CREAM CANCER
US10288401B2 (en) 2015-12-17 2019-05-14 Hubbell Incorporated Multi-function measuring instrument
GB2613378B (en) * 2021-12-02 2023-12-27 Envitec Ltd Cyclone device

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB761171A (en) * 1953-05-29 1956-11-14 Olin Mathieson Heavy-metal salts of 2-mercaptopyridine-1-oxides and methods of preparing same
US2904573A (en) * 1957-05-06 1959-09-15 Ortho Pharma Corp Ferrous citrate complex
US3130204A (en) * 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
US3281366A (en) * 1962-02-09 1966-10-25 Procter & Gamble Synergistic antibacterial compositions
US3236733A (en) * 1963-09-05 1966-02-22 Vanderbilt Co R T Method of combatting dandruff with pyridinethiones metal salts detergent compositions
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US4018907A (en) * 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4225614A (en) * 1977-12-21 1980-09-30 Aktiebolaget Draco Method of treatment for mucocutaneous herpes simplex infections
US4543213A (en) * 1978-07-24 1985-09-24 The United States Of America As Represented By The United States Department Of Energy Process for preparing 2,3-dihydroxybenzoic acid amides of tetraazaalkanes and cycloalkanes
US4279936A (en) * 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
US4442305A (en) * 1981-08-24 1984-04-10 The United States Of America As Represented By The United States Department Of Energy Polycatecholamide chelating agents
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
DE3365971D1 (en) * 1982-03-24 1986-10-16 Nat Res Dev Pharmaceutical compositions containing a complex of iron with n-substituted 3-hydroxypyrid-2-one or -4-one derivatives
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8410289D0 (en) * 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions

Also Published As

Publication number Publication date
US4894455A (en) 1990-01-16
AU584590B2 (en) 1989-06-01
HK97492A (en) 1992-12-11
NZ210057A (en) 1988-08-30
JPH0655722B2 (ja) 1994-07-27
IL73379A (en) 1991-05-12
ZA848501B (en) 1986-06-25
DK162840B (da) 1991-12-16
CA1290096C (en) 1991-10-01
JPS60115564A (ja) 1985-06-22
EP0145228A1 (en) 1985-06-19
GB2148896B (en) 1987-07-29
IE57801B1 (en) 1993-04-07
IL73379A0 (en) 1985-01-31
IE842799L (en) 1985-04-30
PH27408A (en) 1993-06-21
US4665064A (en) 1987-05-12
CY1678A (en) 1993-10-10
GB2148896A (en) 1985-06-05
AU3488484A (en) 1985-05-09
DK162840C (da) 1992-05-04
GB8329043D0 (en) 1983-11-30
DK518984A (da) 1985-05-01
SG101992G (en) 1992-12-04
DE3484098D1 (de) 1991-03-14
GB8427485D0 (en) 1984-12-05
EP0145228B1 (en) 1991-02-06

Similar Documents

Publication Publication Date Title
DK518984A (da) Zinkforbindelser og farmaceutiske praeparater indeholdende disse
DK108388D0 (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK269186A (da) Dipeptidforbindelser med farmaceutisk virkning og praeparater indeholdende disse
DK160557C (da) 1,8-naphthyridinforbindelser og farmaceutiske praeparater indeholdende saadanne
DK162986C (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater indeholdende disse
DK475684D0 (da) Phenothiazinderivater og farmaceutiske praeparater indeholdende phenothiazinderivaterne
DK165693C (da) 2-(n-substitueret guanidino)-4-heteroarylthiazol-forbindelser og farmaceutiske praeparater indeholdende disse
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK78888A (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK375584A (da) Piperidinoquinazolinforbindelser og farmaceutisk praeparat indeholdende en saadan forbindelse
DK162640C (da) N-piperazinylalkanoylanilider og farmaceutiske kompositioner, der indeholder disse forbindelser
DK300984D0 (da) 2-substituerede 6-(alfa-hydroxy)ethyl-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat indeholdende disse
DK21785A (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK154290C (da) Vitamin-d-derivater og farmaceutiske praeparater indeholdende disse
DK81185D0 (da) Carboxicam-enolester-forbindelser og farmaceutiske praeparater indeholdende disse
DK4487D0 (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK489584D0 (da) 6alfa-(1-hydroxyethyl)-2-azacycloalkylthio-2-penem-3-carboxylsyre-forbindelser og farmaceutisk praeparat
DK344384A (da) 2-heterocyclylalkylthio-6-(alfa-hydroxyethyl)-2-penem-3-carboxylsyre-forbindelser og farmaceutiske praeparater indeholdende disse
DK422984D0 (da) Aminocyklopentaner og farmaceutiske praeparater deraf
DK162089C (da) 1-phenoxy-3-hydroxyindolylalkylamino-2-propanoler og farmaceutiske praeparater indeholdende disse
DK488688A (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK547288D0 (da) 5-substituerede-3-phenyl-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidiner og farmaceutiske praeparater indeholdende disse
DK151785A (da) 3-aminoalkylthio-1-phenylindolforbindelser og farmaceutiske praeparater
DK197085D0 (da) Pyrimidinonderivater og farmaceutiske praeparater indeholdende saadanne forbindelser
DK151963C (da) Beta-carbolin-3-oxadiazolylderivater og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
PBP Patent lapsed